Osteopontin and Cancer: Insights into Its Role in Drug Resistance

被引：17
|
作者：
Hao, Chengcheng [1 ,2 ]
Lane, Jane [2 ]
Jiang, Wen G. [2 ]
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Oncol, Beijing 100038, Peoples R China
[2] Cardiff Univ, Div Canc & Genet, Cardiff China Med Res Collaborat, Sch Med, Heath Pk, Cardiff CF14 4XN, Wales
来源：
BIOMEDICINES | 2023年 / 11卷 / 01期
关键词：
osteopontin; cancer; drug resistance; molecular mechanism; LUNG-CANCER; EPIGENETIC MODIFICATIONS; EXPRESSION; CELLS; AUTOPHAGY; CISPLATIN; SENSITIVITY; BIOMARKER; HETEROGENEITY; MECHANISMS;
D O I：
10.3390/biomedicines11010197
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Cancer is one of the leading causes of mortality worldwide. Currently, drug resistance is the main obstacle in cancer treatments with the underlying mechanisms of drug resistance yet to be fully understood. Osteopontin (OPN) is a member of the integrin binding glycophosphoprotein family that is overexpressed in several tumour types. It is involved in drug transport, apoptosis, stemness, energy metabolism, and autophagy, which may contribute to drug resistance. Thus, understanding the role of OPN in cancer drug resistance could be important. This review describes the OPN-based mechanisms that might contribute to cancer drug resistance, demonstrating that OPN may be a viable target for cancer therapy to reduce drug resistance in sensitive tumours.
引用
收藏
页数：18
相关论文
共 50 条
  • [21] New drug development: its role in reversing drug resistance
    Kaye, SB
    BRITISH JOURNAL OF CANCER, 1999, 80 : 116 - 121
  • [22] Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target
    Pan, Yinlong
    Wu, Mengmeng
    Cai, Huazhong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [23] The role of deubiquitinating enzymes in cancer drug resistance
    Parthasaradhireddy Tanguturi
    Kye-Seong Kim
    Suresh Ramakrishna
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 627 - 639
  • [24] The Role of Sphingolipids Metabolism in Cancer Drug Resistance
    Bataller, Marina
    Sanchez-Garcia, Almudena
    Garcia-Mayea, Yoelsis
    Mir, Cristina
    Rodriguez, Isabel
    LLeonart, Matilde Esther
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] The Role of Exosomal microRNA in Cancer Drug Resistance
    Guo, Qiao-ru
    Wang, Hui
    Yan, Ying-da
    Liu, Yun
    Su, Chao-yue
    Chen, Hu-biao
    Yan, Yan-yan
    Adhikari, Rameshwar
    Wu, Qiang
    Zhang, Jian-ye
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [26] The role of microvesicles in cancer progression and drug resistance
    Jorfi, Samireh
    Inal, Jameel M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 293 - 298
  • [27] Dual Role of Mitophagy in Cancer Drug Resistance
    Yan, Chen
    Li, Tao-Sheng
    ANTICANCER RESEARCH, 2018, 38 (02) : 617 - 621
  • [28] The role of circRNA in breast cancer drug resistance
    Yang, Shaofeng
    Li, Donghai
    PEERJ, 2024, 12
  • [29] mTOR: Role in cancer, metastasis and drug resistance
    Murugan, Avaniyapuram Kannan
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 92 - 111
  • [30] The role of deubiquitinating enzymes in cancer drug resistance
    Tanguturi, Parthasaradhireddy
    Kim, Kye-Seong
    Ramakrishna, Suresh
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (04) : 627 - 639
12345